User:Rupertdonovan/sandbox: Difference between revisions
Content deleted Content added
Infobox person |
Background |
||
| Line 17: | Line 17: | ||
}} |
}} |
||
'''John R. Stuelpnagel''' is an [[USA|American]] [[venture capitalist]], [[inventor]], [[ medical researcher]] and [[publicist]], specializing in [[biotechnology]].<ref name="MedCityNews">{{cite web|url=https://medcitynews.com/2015/01/future-next-gen-sequencing-illumina-cofounders-never-genome-mapped/|title=The future of next-gen sequencing (and why an Illumina cofounder’s never had his genome mapped) |publisher=MedCityNews}}</ref><ref>{{cite web|url=https://medium.com/@axialxyz/eight-lessons-from-john-stuelpnagel-illumina-ca95ad7b59eb |title=Eight Lessons from John Stuelpnagel (Illumina) |publisher=Medium}}</ref><ref>{{cite web|url=https://min.news/en/tech/764027bcc054ec7384e9c56ab7ef906e.html|title=Illumina's original people are coming soon, and the mysterious Chu CHUANG, who is at the helm of the Chinese executives, has attracted $400 million in 4 years to build a cheaper DNA sequencer |publisher=MinNews }}</ref> He is mostly known for business and research contributions to [[DNA sequencing]] technology through co-founding [[Illumina, Inc.]],<ref name="Illumina">{{Cite web|title=Illumina- The Origin story|url=https://www.linkedin.com/pulse/illumina-origin-story-tony-czarnik|website=www.linkedin.com|language=en}}</ref><ref>{{cite web|url=https://seekingalpha.com/article/4381959-illumina-cheap-upside-from-grail |title=Illumina: Cheap With Further Upside From Grail |publisher=Seeking Alpha }}</ref> a company that helped to reduce the cost of sequencing a [[human genome]].<ref name="UC Davis">{{cite web|url=https://awards.vetmed.ucdavis.edu/aaa/2017-alumni-achievement-award-recipients|title=2017 Alumni Achievement Award Recipients |publisher=UC Davis Veterinary Medicine }}</ref><ref name="ibs">{{cite journal|url= https://www.icmrindia.org/casestudies/catalogue/Business%20Strategy/illumina-maintaining-growth-momentum-excerpts.htm |title=Illumina-Maintaining Growth Momentum in a Plateauing Genome Sequencing Market|journal=IBS Center for Management Research |date=2017 |pages=18 |doi= }}</ref><ref name=":0">{{cite news|title=Illumina's CEO on the Promise of the $1,000 Genome -- And the Work That Remains |url=https://www.vox.com/2014/3/25/11624902/illuminas-ceo-on-the-promise-of-the-1000-genome-and-the-work-that|work=Recode|date=March 25, 2014|language=en}}</ref> Stuelpnagel has also co-founded and ran multiple early-stage growth companies related to biotechnologies or [[genomics]].<ref name="WSJ">{{cite web|url=https://www.wsj.com/market-data/quotes/TXG/company-people/executive-profile/79243066|title=John R. Stuelpnagel, Chairman, 10X Genomics, Inc. |publisher=Wall Street Journal Markets }}</ref><ref name="screener">{{cite web|url=https://www.marketscreener.com/business-leaders/John-Stuelpnagel-12660/biography/|title=John Stuelpnagel |publisher=MarketScreener }}</ref> Stuelpnagel holds 35 issued U.S. patents.<ref name="UC Davis"/><ref name="patents">{{cite web|url=https://patents.justia.com/inventor/john-r-stuelpnagel |title=Patents by Inventor John R. Stuelpnagel |publisher=Justia Patents}}</ref> |
'''John R. Stuelpnagel''' is an [[USA|American]] [[venture capitalist]], [[inventor]], [[ medical researcher]] and [[publicist]], specializing in [[biotechnology]].<ref name="MedCityNews">{{cite web|url=https://medcitynews.com/2015/01/future-next-gen-sequencing-illumina-cofounders-never-genome-mapped/|title=The future of next-gen sequencing (and why an Illumina cofounder’s never had his genome mapped) |publisher=MedCityNews}}</ref><ref>{{cite web|url=https://medium.com/@axialxyz/eight-lessons-from-john-stuelpnagel-illumina-ca95ad7b59eb |title=Eight Lessons from John Stuelpnagel (Illumina) |publisher=Medium}}</ref><ref>{{cite web|url=https://min.news/en/tech/764027bcc054ec7384e9c56ab7ef906e.html|title=Illumina's original people are coming soon, and the mysterious Chu CHUANG, who is at the helm of the Chinese executives, has attracted $400 million in 4 years to build a cheaper DNA sequencer |publisher=MinNews }}</ref> He is mostly known for business and research contributions to [[DNA sequencing]] technology through co-founding [[Illumina, Inc.]],<ref name="Illumina">{{Cite web|title=Illumina- The Origin story|url=https://www.linkedin.com/pulse/illumina-origin-story-tony-czarnik|website=www.linkedin.com|language=en}}</ref><ref>{{cite web|url=https://seekingalpha.com/article/4381959-illumina-cheap-upside-from-grail |title=Illumina: Cheap With Further Upside From Grail |publisher=Seeking Alpha }}</ref> a company that helped to reduce the cost of sequencing a [[human genome]].<ref name="UC Davis">{{cite web|url=https://awards.vetmed.ucdavis.edu/aaa/2017-alumni-achievement-award-recipients|title=2017 Alumni Achievement Award Recipients |publisher=UC Davis Veterinary Medicine }}</ref><ref name="ibs">{{cite journal|url= https://www.icmrindia.org/casestudies/catalogue/Business%20Strategy/illumina-maintaining-growth-momentum-excerpts.htm |title=Illumina-Maintaining Growth Momentum in a Plateauing Genome Sequencing Market|journal=IBS Center for Management Research |date=2017 |pages=18 |doi= }}</ref><ref name=":0">{{cite news|title=Illumina's CEO on the Promise of the $1,000 Genome -- And the Work That Remains |url=https://www.vox.com/2014/3/25/11624902/illuminas-ceo-on-the-promise-of-the-1000-genome-and-the-work-that|work=Recode|date=March 25, 2014|language=en}}</ref> Stuelpnagel has also co-founded and ran multiple early-stage growth companies related to biotechnologies or [[genomics]].<ref name="WSJ">{{cite web|url=https://www.wsj.com/market-data/quotes/TXG/company-people/executive-profile/79243066|title=John R. Stuelpnagel, Chairman, 10X Genomics, Inc. |publisher=Wall Street Journal Markets }}</ref><ref name="screener">{{cite web|url=https://www.marketscreener.com/business-leaders/John-Stuelpnagel-12660/biography/|title=John Stuelpnagel |publisher=MarketScreener }}</ref> Stuelpnagel holds 35 issued U.S. patents.<ref name="UC Davis"/><ref name="patents">{{cite web|url=https://patents.justia.com/inventor/john-r-stuelpnagel |title=Patents by Inventor John R. Stuelpnagel |publisher=Justia Patents}}</ref> |
||
== Background == |
|||
Revision as of 10:21, 21 August 2021
John Stuelpnagel | |
|---|---|
| Born | John R. Stuelpnagel |
| Nationality | American |
| Alma mater | University of California, Davis (B.S) (D.V.M.) UCLA Anderson School of Management (MBA) |
| Occupation(s) | Founder and CEO of Illumina, Inc. (1998 - 2009) Chairman and Co-founder of Fabric Genomics (2009 - Present) Chairman of 10x Genomics (2013 - Present) |
| Website | fabricgenomics |
John R. Stuelpnagel is an American venture capitalist, inventor, medical researcher and publicist, specializing in biotechnology.[1][2][3] He is mostly known for business and research contributions to DNA sequencing technology through co-founding Illumina, Inc.,[4][5] a company that helped to reduce the cost of sequencing a human genome.[6][7][8] Stuelpnagel has also co-founded and ran multiple early-stage growth companies related to biotechnologies or genomics.[9][10] Stuelpnagel holds 35 issued U.S. patents.[6][11]
Background
- ^ "The future of next-gen sequencing (and why an Illumina cofounder's never had his genome mapped)". MedCityNews.
- ^ "Eight Lessons from John Stuelpnagel (Illumina)". Medium.
- ^ "Illumina's original people are coming soon, and the mysterious Chu CHUANG, who is at the helm of the Chinese executives, has attracted $400 million in 4 years to build a cheaper DNA sequencer". MinNews.
- ^ "Illumina- The Origin story". www.linkedin.com.
- ^ "Illumina: Cheap With Further Upside From Grail". Seeking Alpha.
- ^ a b "2017 Alumni Achievement Award Recipients". UC Davis Veterinary Medicine.
- ^ "Illumina-Maintaining Growth Momentum in a Plateauing Genome Sequencing Market". IBS Center for Management Research: 18. 2017.
- ^ "Illumina's CEO on the Promise of the $1,000 Genome -- And the Work That Remains". Recode. March 25, 2014.
- ^ "John R. Stuelpnagel, Chairman, 10X Genomics, Inc". Wall Street Journal Markets.
- ^ "John Stuelpnagel". MarketScreener.
- ^ "Patents by Inventor John R. Stuelpnagel". Justia Patents.